UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DIAPH3 deficiency links microtubules to mitotic errors, defective neurogenesis, and brain dysfunction

eLife, 2021-04, Vol.10

2021

Volltextzugriff (PDF)

Aberrant generation of dentate gyrus granule cells is associated with epileptic susceptibility in p53 conditional knockout mice

Frontiers in neuroscience, 2024-08, Vol.18, p.1418973

2024

Volltextzugriff (PDF)

DIAPH3 predicts survival of patients with MGMT -methylated glioblastoma

Frontiers in oncology, 2024-02, Vol.14, p.1359652-1359652

2024

Volltextzugriff (PDF)

KIF2A deficiency causes early-onset neurodegeneration

Proceedings of the National Academy of Sciences - PNAS, 2022-11, Vol.119 (46), p.e2209714119-e2209714119

2022

Volltextzugriff (PDF)

Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics

Acta neurochirurgica, 2023-04, Vol.165 (4), p.1075-1085

2023

Volltextzugriff (PDF)

Pyridoxamine-phosphate oxidases and pyridoxamine-phosphate oxidase-related proteins catalyze the oxidation of 6-NAD(P)H to NAD(P)

Biochemical journal, 2019-10, Vol.476 (20), p.3033-3052

2019

Volltextzugriff (PDF)

A five-year experience in conformational radiotherapy in the treatment of prostate cancer. Evaluation of acute toxicity in 131 patients

Progrès en urologie (Paris), 2005-02, Vol.15 (1), p.36

2005

Volltextzugriff (PDF)

Radiothérapie conformationnelle dans le traitement du cancer de la prostate. Evaluation de la toxicité aiguë chez 131 patients

Progrès en urologie (Paris), 2005-02, Vol.15 (1), p.36-39

2005

Volltextzugriff (PDF)

Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate Cancer

Cancer discovery, 2024-01, Vol.14 (1), p.20-22

2024

Volltextzugriff (PDF)

Culture Change for the Analytical Mind

Strategic finance (Montvale, N.J.), 2006-06, Vol.87 (12), p.11

2006

Volltextzugriff (PDF)

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor

Cancer, 2024-08, Vol.130 (15), p.2621-2628

2024

Volltextzugriff (PDF)

Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting

The Prostate, 2024-06, Vol.84 (9), p.888-892

2024

Volltextzugriff (PDF)

Change Point Detection in Radar Reflectivity Measurements Contaminated by Speckle Noise

IEEE journal of selected topics in applied earth observations and remote sensing, 2024, Vol.17, p.11208-11218

2024

Volltextzugriff (PDF)

Accelerating the Discovery of New DP Steel Using Machine Learning-Based Multiscale Materials Simulations

Metallurgical and materials transactions. A, Physical metallurgy and materials science, 2020-06, Vol.51 (6), p.3268-3279

2020

Volltextzugriff (PDF)

Revolutionizing sheet metal stamping through industry 5.0 digital twins: a comprehensive review

Journal of intelligent manufacturing, 2024-07

2024

Volltextzugriff (PDF)

Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma

Diagnostics (Basel), 2024-08, Vol.14 (17), p.1899

2024

Volltextzugriff (PDF)

The utility of ChatGPT in subspecialty consultation for patients (pts) with metastatic genitourinary (GU) cancer

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.227-227

2024

Volltextzugriff (PDF)

Comparative effectiveness of ChatGPT 4.0 and medical oncologists in telemedicine-based management of metastatic prostate carcinoma (mPC)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.226-226

2024

Volltextzugriff (PDF)

Comparative effectiveness of first-line (1L) ipilimumab plus nivolumab (Ipi + Nivo) versus immune checkpoint inhibitors + tyrosine kinase inhibitors (ICI + TKI) in patients (pts) with intermediate or poor (I/P) risk metastatic clear cell renal cell carcinoma (mccRCC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4557-4557

2024

Volltextzugriff (PDF)

Changes in treatment (Rx) patterns and attrition rates in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4527-4527

2024

Volltextzugriff (PDF)

Treatment (Rx) trends and attrition with lines of therapy in patients (pts) with advanced urothelial carcinoma (aUC)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.562-562

2024

Volltextzugriff (PDF)

Baseline bone pain as a prognostic marker for survival for men with metastatic hormone-sensitive prostate cancer (mHSPC): Patient-level analysis of SWOG 1216 trial

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.188-188

2024

Volltextzugriff (PDF)

Disease characteristics, survival outcomes, and tumor molecular landscape in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) harboring CDK12 alterations ( CDK12a ) receiving intensified androgen deprivation therapy (ADTi)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.189-189

2024

Volltextzugriff (PDF)

Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy (iADT) with relugolix

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.70-70

2024

Volltextzugriff (PDF)

Disparities in the incidence of next-generation sequencing (NGS) among patients (pts) with advanced or metastatic prostate cancer (mPC) and urothelial carcinoma (mUC)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.542-542

2024

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

DIAPH3 deficiency links microtubules to mitotic errors, defective neurogenesis, and brain dysfunction

Aberrant generation of dentate gyrus granule cells is associated with epileptic susceptibility in p53 conditional knockout mice

DIAPH3 predicts survival of patients with MGMT -methylated glioblastoma

KIF2A deficiency causes early-onset neurodegeneration

Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics

Pyridoxamine-phosphate oxidases and pyridoxamine-phosphate oxidase-related proteins catalyze the oxidation of 6-NAD(P)H to NAD(P)

A five-year experience in conformational radiotherapy in the treatment of prostate cancer. Evaluation of acute toxicity in 131 patients

Radiothérapie conformationnelle dans le traitement du cancer de la prostate. Evaluation de la toxicité aiguë chez 131 patients

Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate Cancer

Culture Change for the Analytical Mind

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor

Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting

Change Point Detection in Radar Reflectivity Measurements Contaminated by Speckle Noise

Accelerating the Discovery of New DP Steel Using Machine Learning-Based Multiscale Materials Simulations

Revolutionizing sheet metal stamping through industry 5.0 digital twins: a comprehensive review

Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma

The utility of ChatGPT in subspecialty consultation for patients (pts) with metastatic genitourinary (GU) cancer

Comparative effectiveness of ChatGPT 4.0 and medical oncologists in telemedicine-based management of metastatic prostate carcinoma (mPC)

Comparative effectiveness of first-line (1L) ipilimumab plus nivolumab (Ipi + Nivo) versus immune checkpoint inhibitors + tyrosine kinase inhibitors (ICI + TKI) in patients (pts) with intermediate or poor (I/P) risk metastatic clear cell renal cell carcinoma (mccRCC)

Changes in treatment (Rx) patterns and attrition rates in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Treatment (Rx) trends and attrition with lines of therapy in patients (pts) with advanced urothelial carcinoma (aUC)

Baseline bone pain as a prognostic marker for survival for men with metastatic hormone-sensitive prostate cancer (mHSPC): Patient-level analysis of SWOG 1216 trial

Disease characteristics, survival outcomes, and tumor molecular landscape in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) harboring CDK12 alterations ( CDK12a ) receiving intensified androgen deprivation therapy (ADTi)

Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy (iADT) with relugolix

Disparities in the incidence of next-generation sequencing (NGS) among patients (pts) with advanced or metastatic prostate cancer (mPC) and urothelial carcinoma (mUC)

Suchergebnisse filtern